- Tytuł:
- Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study
- Autorzy:
- Źródło:
- In The Lancet Oncology August 2023 24(8):913-924
Czasopismo naukowe